“Bimekizumab 3-Year Efficacy in High-Impact Areas in Moderate to Severe Plaque Psoriasis: Pooled Results from Five Phase 3 3b Trials”. SKIN The Journal of Cutaneous Medicine 8, no. 1 (January 16, 2024): s304. Accessed June 25, 2025. https://skin.dermsquared.com/skin/article/view/2446.